Whelan Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Whelan Financial's ABBV Position: Q3 2026 in Review
Whelan Financial increased its AbbVie (ABBV) stake by 16% in Q3 2026, buying an estimated $67.9K and bringing the position to 1,962 shares worth $513K. The position accounts for 0.13% of the portfolio, ranked #57.
Whelan Financial first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,250 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Whelan Financial held 1,962 shares of AbbVie worth $513K as of Q3 2026.
- Whelan Financial bought 265 AbbVie shares in Q3 2026, an estimated $67.9K.
- AbbVie made up 0.13% of Whelan Financial's portfolio in Q3 2026, its #57 holding.
- Whelan Financial first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- 4,250 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Whelan Financial's 13F filing for Q3 2026, filed 28 Oct 2026.